Cargando…
Pharmacogenomics Guided-Personalization of Warfarin and Tamoxifen
The use of pharmacogenomics to personalize drug therapy has been a long-sought goal for warfarin and tamoxifen. However, conflicting evidence has created reason for hesitation in recommending pharmacogenomics-guided care for both drugs. This review will provide a summary of the evidence to date on t...
Autores principales: | Wigle, Theodore J., Jansen, Laura E., Teft, Wendy A., Kim, Richard B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748632/ https://www.ncbi.nlm.nih.gov/pubmed/29236081 http://dx.doi.org/10.3390/jpm7040020 |
Ejemplares similares
-
Ethnic Diversity and Warfarin Pharmacogenomics
por: Asiimwe, Innocent G., et al.
Publicado: (2022) -
Profound reduction in tamoxifen active metabolite endoxifen in a breast cancer patient treated with rifampin prior to initiation of an anti-TNFα biologic for ulcerative colitis: a case report
por: Henderson, Sara L., et al.
Publicado: (2016) -
Impact of CYP2C9‐Interacting Drugs on Warfarin Pharmacogenomics
por: Agrawal, Saaket, et al.
Publicado: (2020) -
Hypercoagulation from Concomitant Administration of Tamoxifen and Warfarin
por: Panahi, Ladan, et al.
Publicado: (2020) -
Verification of five pharmacogenomics-based warfarin administration models
por: Lin, Meiqin, et al.
Publicado: (2016)